Is transplant success linked to donor CMV serostatus?
作者信息
Devine Steven M
机构信息
Center for International Blood and Marrow Transplant Research, NMDP, Minneapolis, MN.
出版信息
Blood Adv. 2025 May 13;9(9):2354-2355. doi: 10.1182/bloodadvances.2025015934.
Abstract
摘要
相似文献
1
Is transplant success linked to donor CMV serostatus?移植成功率与供体巨细胞病毒血清学状态有关吗？
Blood Adv. 2025 May 13;9(9):2354-2355. doi: 10.1182/bloodadvances.2025015934.
2
Impact of donor and recipient cytomegalovirus serology on long-term survival of heart transplant recipients.供体和受体巨细胞病毒血清学对心脏移植受者长期生存的影响。
Transpl Infect Dis. 2019 Feb;21(1):e13015. doi: 10.1111/tid.13015. Epub 2018 Nov 19.
3
Unknown cytomegalovirus serostatus in primary immunodeficiency disorders: A new category of transplant recipients.原发性免疫缺陷疾病中未知巨细胞病毒血清状态：一类新的移植受者。
Transpl Infect Dis. 2021 Apr;23(2):e13504. doi: 10.1111/tid.13504. Epub 2020 Nov 29.
4
Role of Donor Cytomegalovirus Serostatus in Cytomegalovirus-Seronegative Recipients of Unrelated Donor Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide Prophylaxis.供体巨细胞病毒血清学状态在接受移植后环磷酰胺预防的无关供体造血细胞移植的巨细胞病毒血清阴性受者中的作用。
Transplant Cell Ther. 2025 May 14. doi: 10.1016/j.jtct.2025.05.005.
5
Impact of donor and recipient cytomegalovirus serology on long-term survival of lung transplant recipients.供体和受体巨细胞病毒血清学对肺移植受者长期生存的影响。
Transpl Infect Dis. 2018 Oct;20(5):e12964. doi: 10.1111/tid.12964. Epub 2018 Jul 20.
6
Donor and recipient CMV serostatus and antigenemia after renal transplantation: an analysis of 486 patients.肾移植后供体和受体的巨细胞病毒血清学状态及抗原血症：486例患者的分析
J Clin Virol. 2008 Feb;41(2):92-5. doi: 10.1016/j.jcv.2007.10.006. Epub 2007 Nov 26.
7
The association of cytomegalovirus infection and cytomegalovirus serostatus with invasive fungal infections in allogeneic haematopoietic stem cell transplant recipients: a systematic review and meta-analysis.巨细胞病毒感染和巨细胞病毒血清状态与异基因造血干细胞移植受者侵袭性真菌感染的关系：系统评价和荟萃分析。
Clin Microbiol Infect. 2022 Mar;28(3):332-344. doi: 10.1016/j.cmi.2021.10.008. Epub 2021 Nov 6.
8
Impact of pretransplant donor and recipient cytomegalovirus serostatus on outcome for multiple myeloma patients undergoing reduced intensity conditioning allogeneic stem cell transplantation.移植前供体和受者巨细胞病毒血清状态对接受低强度预处理异基因造血干细胞移植的多发性骨髓瘤患者结局的影响。
Mediterr J Hematol Infect Dis. 2013 Apr 10;5(1):e2013026. doi: 10.4084/MJHID.2013.026. Print 2013.
9
CMV infection after transplant from cord blood compared to other alternative donors: the importance of donor-negative CMV serostatus.与其他替代供体相比，来自脐血的 CMV 感染移植：供体阴性 CMV 血清学状态的重要性。
Biol Blood Marrow Transplant. 2012 Jan;18(1):92-9. doi: 10.1016/j.bbmt.2011.05.015. Epub 2011 May 27.
10
CMV Serostatus of Donor-Recipient Pairs Influences the Risk of CMV Infection/Reactivation in HSCT Patients.供受者对的巨细胞病毒血清学状态影响造血干细胞移植患者巨细胞病毒感染/再激活的风险。
Bone Marrow Res. 2012;2012:375075. doi: 10.1155/2012/375075. Epub 2012 Nov 22.
本文引用的文献
1
Impacts of donor age and HLA mismatch on HCT outcomes differ according to the donor CMV serostatus in unrelated allo-HCT.在非亲缘异基因造血细胞移植中，根据供者巨细胞病毒血清学状态的不同，供者年龄和人类白细胞抗原错配对造血细胞移植结果的影响也有所不同。
Blood Adv. 2025 May 13;9(9):2356-2365. doi: 10.1182/bloodadvances.2024014408.
2
Novel machine learning technique further clarifies unrelated donor selection to optimize transplantation outcomes.新型机器学习技术进一步明确无关供体选择以优化移植结果。
Blood Adv. 2024 Dec 10;8(23):6082-6087. doi: 10.1182/bloodadvances.2024013756.
3
Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis Attenuates Disparity in Outcomes Between Use of Matched or Mismatched Unrelated Donors.移植后环磷酰胺为主的移植物抗宿主病预防方案可减轻匹配或不匹配非亲缘供者使用导致的结局差异。
J Clin Oncol. 2024 Oct;42(28):3277-3286. doi: 10.1200/JCO.24.00184. Epub 2024 Jul 17.
4
Younger unrelated donors may be preferable over HLA match in the PTCy era: a study from the ALWP of the EBMT.在 PTCy 时代，年轻的非亲属供者可能优于 HLA 匹配：来自 EBMT 的 ALWP 的研究。
Blood. 2024 Jun 13;143(24):2534-2543. doi: 10.1182/blood.2023023697.
5
How I prevent GVHD in high-risk patients: posttransplant cyclophosphamide and beyond.我如何预防高危患者的移植物抗宿主病：移植后环磷酰胺及其他方法。
Blood. 2023 Jan 5;141(1):49-59. doi: 10.1182/blood.2021015129.
6
Development of an Unrelated Donor Selection Score Predictive of Survival after HCT: Donor Age Matters Most.无关供者选择评分的开发可预测 HCT 后的生存：供者年龄最重要。
Biol Blood Marrow Transplant. 2018 May;24(5):1049-1056. doi: 10.1016/j.bbmt.2018.02.006. Epub 2018 Feb 14.
7
The role of cytomegalovirus serostatus on outcome of hematopoietic stem cell transplantation.巨细胞病毒血清学状态对造血干细胞移植结局的作用。
Curr Opin Hematol. 2014 Nov;21(6):466-9. doi: 10.1097/MOH.0000000000000085.
8
High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation.高分辨率的供受者人类白细胞抗原（HLA）配型有助于无关供者骨髓移植的成功。
Blood. 2007 Dec 15;110(13):4576-83. doi: 10.1182/blood-2007-06-097386. Epub 2007 Sep 4.
9
Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age.无关供体骨髓移植后受体中作为风险因素的供体特征：供体年龄的影响
Blood. 2001 Oct 1;98(7):2043-51. doi: 10.1182/blood.v98.7.2043.
Zotero 插件